Evogene Ltd

EVGN70

Penny Stock

$1.64arrow_drop_up1.79%$0.02

Penny Stock

EVGN70

$1.64

arrow_drop_up1.79%$0.02

Penny Stock

Performance History

Key Stats
Open	$1.59
Prev. Close	$1.60
EPS	-3.84
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$8.69M
PE Ratio	-

	LOW	HIGH
Day Range	1.50	1.67
52 Week Range	1.48	10.40

Ratios







EPS	-3.84

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Evogene Ltd (EVGN)

Evogene Ltd (EVGN) is an agricultural biotechnology company that specializes in developing innovative solutions for crop productivity and yield. With a focus on plant genomics, the company utilizes cutting-edge technologies to enhance various traits of plants, including yield, drought tolerance, and disease resistance. By harnessing the power of computational biology and precision breeding, Evogene aims to create sustainable solutions for the global food and agriculture industry.

In terms of its stock price history, EVGN has shown both volatility and growth over the years. Like many other biotech companies, the stock price can be influenced by factors such as clinical trial results, regulatory approvals, and market sentiment. Investors interested in EVGN should closely monitor these factors and conduct thorough analysis before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Ofer Haviv CPA
Headquarters: Rehovot
Employees: 137
Exchange: NASDAQ

Keep an eye on Evogene Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Evogene Ltd's (EVGN) price per share?

The current price per share for Evogene Ltd (EVGN) is $1.65. The stock has seen a price change of $0.03 recently, indicating a 1.79% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Evogene Ltd (EVGN)?

For Evogene Ltd (EVGN), the 52-week high is $10.4, which is 530.69% from the current price. The 52-week low is $1.49, the current price is 11.04% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Evogene Ltd (EVGN) a growth stock?

Evogene Ltd (EVGN) has shown an average price growth of -3.36% over the past three years. It has received a score of 82 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Evogene Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Evogene Ltd (EVGN) stock price performance year to date (YTD)?

As of the latest data, Evogene Ltd (EVGN) has a year-to-date price change of -81.07%. Over the past month, the stock has experienced a price change of -31.29%. Over the last three months, the change has been -54.45%. Over the past six months, the figure is -79.89%. Looking at a longer horizon, the five-year price change stands at -88.47%.

help

Is Evogene Ltd (EVGN) a profitable company?

Evogene Ltd (EVGN) has a net income of -$25.95M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 24.8% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -667.07% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $5.64M, although specific revenue growth data is currently not available. The gross profit is $1.4M. Operating income is noted at -$26.39M. Furthermore, the EBITDA is -$19.67M.

help

What is the market capitalization of Evogene Ltd (EVGN)?

Evogene Ltd (EVGN) has a market capitalization of $8.85M. The average daily trading volume is 1.62, indicating the stock's liquidity and investor engagement.